|
CCDC43 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.258600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.773800E-01 |
| Normal-vs-Stage2 |
2.053000E-01 |
| Normal-vs-Stage3 |
2.156200E-01 |
| Normal-vs-Stage4 |
1.209390E-01 |
| Stage1-vs-Stage2 |
1.220800E-01 |
| Stage1-vs-Stage3 |
1.597570E-01 |
| Stage1-vs-Stage4 |
7.799600E-02 |
| Stage2-vs-Stage3 |
1.317870E-02 |
| Stage2-vs-Stage4 |
1.103850E-02 |
| Stage3-vs-Stage4 |
7.164200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.444200E-01 |
| Normal-vs-AfricanAmerican |
4.305400E-01 |
| Normal-vs-Asian |
4.884200E-01 |
| Caucasian-vs-AfricanAmerican |
1.393760E-01 |
| Caucasian-vs-Asian |
9.094000E-02 |
| AfricanAmerican-vs-Asian |
8.693800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.844820E-01 |
| Normal-vs-Female |
9.993600E-01 |
| Male-vs-Female |
5.394100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.563600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.763200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.530800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.445000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.228800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.770000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.679800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.184800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.346800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.885600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.635000E-01 |
| Classical-VS-Follicular |
3.466000E-01 |
| Classical-VS-Other |
2.407400E-01 |
| Classical-VS-Normal |
9.287000E-01 |
| Tall-VS-Follicular |
8.472200E-02 |
| Tall-VS-Other |
5.088800E-01 |
| Tall-VS-Normal |
2.630200E-01 |
| Follicular-VS-Other |
1.998570E-01 |
| Follicular-VS-Normal |
5.096200E-01 |
| Other-VS-Normal |
1.963210E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.333000E-01 |
| Normal-vs-N1 |
2.603400E-01 |
| N0-vs-N1 |
2.999400E-01 |
|
|
